- Home
- XERS vs NFE Comparison
XERS vs NFE Comparison
Compare XERS & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- NFE
- Stock Information
- Founded
- XERS 2005
- NFE 2014
- Country
- XERS United States
- NFE United States
- Employees
- XERS 394
- NFE N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- NFE Oil/Gas Transmission
- Sector
- XERS Health Care
- NFE Utilities
- Exchange
- XERS Nasdaq
- NFE Nasdaq
- Market Cap
- XERS 1.3B
- NFE 773.2M
- IPO Year
- XERS 2018
- NFE 2019
- Fundamental
- Price
- XERS $7.98
- NFE $2.54
- Analyst Decision
- XERS Strong Buy
- NFE Strong Buy
- Analyst Count
- XERS 7
- NFE 6
- Target Price
- XERS $8.00
- NFE $8.92
- AVG Volume (30 Days)
- XERS 3.5M
- NFE 8.1M
- Earning Date
- XERS 08-07-2025
- NFE 09-09-2025
- Dividend Yield
- XERS N/A
- NFE N/A
- EPS Growth
- XERS N/A
- NFE N/A
- EPS
- XERS N/A
- NFE N/A
- Revenue
- XERS $246,025,000.00
- NFE $2,127,808,000.00
- Revenue This Year
- XERS $43.89
- NFE $7.43
- Revenue Next Year
- XERS $20.40
- NFE $8.38
- P/E Ratio
- XERS N/A
- NFE N/A
- Revenue Growth
- XERS 35.62
- NFE N/A
- 52 Week Low
- XERS $2.48
- NFE $2.01
- 52 Week High
- XERS $8.02
- NFE $16.66
- Technical
- Relative Strength Index (RSI)
- XERS 80.36
- NFE 44.98
- Support Level
- XERS $7.27
- NFE $2.43
- Resistance Level
- XERS $8.02
- NFE $2.76
- Average True Range (ATR)
- XERS 0.32
- NFE 0.21
- MACD
- XERS 0.03
- NFE 0.05
- Stochastic Oscillator
- XERS 93.99
- NFE 65.15
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About NFE New Fortress Energy Inc.
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.